There is no single “best” medication for neuropathy. The most effective option depends on the type of neuropathy you have, your other health conditions, and how you respond to treatment. That said, the medications with the strongest evidence fall into two main categories: certain antidepressants and certain anticonvulsants. For the most common form, diabetic peripheral neuropathy, duloxetine and pregabalin are the only two drugs with full FDA approval, making them the usual starting points.
First-Line Options: Antidepressants and Anticonvulsants
The drugs most commonly prescribed for neuropathic pain weren’t originally designed for it. They were developed to treat depression or seizures, but they also interrupt the faulty nerve signals that cause burning, tingling, and shooting pain. The two classes that perform best in clinical trials are SNRIs (a type of antidepressant) and gabapentinoids (a type of anticonvulsant).
Duloxetine, an SNRI, works by increasing the activity of two chemical messengers in the spinal cord that help dampen pain signals. In a controlled trial of patients with diabetic neuropathy and no depression, duloxetine at a standard daily dose separated from placebo within the first week of treatment, with improvements across nearly all pain measures. Importantly, taking a higher dose didn’t produce significantly better results than the standard dose, which means most people get the full benefit without needing to push the dose upward.
Pregabalin and gabapentin, the two gabapentinoids, work differently. They calm overexcited nerve cells by blocking a specific calcium channel involved in pain signaling. A retrospective analysis of nine clinical trials found that patients who respond to pregabalin typically notice meaningful pain reduction within the first one to two days of treatment. That’s faster than many people expect. If you haven’t noticed any improvement after several weeks, the medication likely isn’t going to work for you, and it’s worth discussing alternatives.
How These Medications Compare
Head-to-head research comparing pregabalin and gabapentin shows they are broadly similar in effectiveness for neuropathic pain. The practical differences come down to dosing convenience and predictability. Pregabalin is absorbed more consistently, so its effects are more predictable from person to person. Gabapentin absorption becomes less efficient at higher doses, which sometimes means results vary. Low doses of gabapentin are generally considered up to 1,800 mg per day, while pregabalin’s threshold sits around 300 mg per day.
Duloxetine tends to cause different side effects than the gabapentinoids, which sometimes makes the choice straightforward. If one class causes problems you can’t tolerate, the other class is a reasonable next step.
Side Effects to Expect
Gabapentin and pregabalin share a similar side effect profile. The most common complaints are dizziness, drowsiness, dry mouth, swelling in the hands or feet, blurred vision, and weight gain. Many patients describe a cluster of cognitive effects they call “brain fog,” including difficulty concentrating, short-term memory lapses, and a general feeling of mental dullness. These effects are often worst during the first few weeks and may ease as your body adjusts.
Duloxetine’s most common side effects are nausea, dry mouth, fatigue, and constipation. It tends to cause less weight gain and sedation than the gabapentinoids, which is one reason some clinicians reach for it first. However, it can raise blood pressure slightly, so it’s not always ideal for people with uncontrolled hypertension.
Older tricyclic antidepressants like amitriptyline and nortriptyline also relieve neuropathic pain and have decades of use behind them. They work through a separate mechanism and can be effective, particularly for pain after shingles. But they carry more serious risks for people with heart disease, seizure disorders, or certain other conditions, which limits who can safely take them. For younger, otherwise healthy patients, they remain a viable option.
Why the Cause of Your Neuropathy Matters
Not all neuropathy responds to the same treatments. This is one of the most important things to understand when searching for the “best” medication. Chemotherapy-induced neuropathy, for example, is notoriously difficult to treat. The only drug with a formal recommendation for it is duloxetine. Gabapentin, pregabalin, and tricyclic antidepressants are still considered investigational for chemo-related nerve pain, meaning the evidence isn’t strong enough to confidently recommend them for that specific cause.
For diabetic neuropathy, both duloxetine and pregabalin have strong evidence. For pain after shingles (postherpetic neuralgia), gabapentin and pregabalin carry FDA approval. Knowing what’s causing your neuropathy helps narrow the list of medications most likely to help.
Topical Treatments for Localized Pain
If your pain is concentrated in a specific area, topical options can provide relief without the systemic side effects of oral medications. High-concentration capsaicin patches (8%) are applied in a clinical setting and work by overwhelming and then desensitizing the nerve endings in the skin. A study of 120 patients found that about 41% experienced at least a 30% reduction in pain intensity within 15 days of a single application, and that relief held steady through the 12-week follow-up. Roughly 30% of patients achieved a 50% or greater reduction. The advantage is that one application can last weeks to months, avoiding the daily pill routine entirely.
Lidocaine patches are another topical option, particularly for postherpetic neuralgia. They numb the area directly and carry minimal risk of systemic side effects. Both the CDC and major pain guidelines list capsaicin and lidocaine patches as reasonable options for neuropathic pain.
Where Opioids Fit In
Opioids are not recommended as a first-line or routine treatment for neuropathic pain. The CDC’s 2022 prescribing guideline is clear on this: there is insufficient evidence that opioids provide long-term benefits for chronic pain, and the risks, which increase with dose, are well documented. Clinicians are directed to maximize non-opioid options first. Opioids may enter the conversation only when other treatments have failed and the expected benefits clearly outweigh the risks for that individual patient.
Supplements: What the Evidence Shows
Alpha-lipoic acid is the supplement most frequently discussed for neuropathy, particularly the diabetic type. It’s an antioxidant that has been studied at doses of 600, 1,200, and 1,800 mg per day. The results, however, are underwhelming. A meta-analysis found that oral alpha-lipoic acid did not produce favorable results on standard measures of nerve pain, nerve sensitivity, or nerve conduction. Some people report mild symptom improvement, but the clinical evidence doesn’t support it as a reliable treatment. It’s unlikely to cause harm at standard doses, but it shouldn’t replace proven medications.
A Practical Approach to Finding What Works
Treatment for neuropathy is almost always a process of trial and adjustment rather than a single prescription that solves everything. Most clinicians start with either duloxetine or a gabapentinoid based on your specific diagnosis, other medications you’re taking, and which side effect profile is more acceptable to you. If the first option doesn’t provide enough relief or causes intolerable side effects, switching to the other class is the standard next step. Some people end up combining medications from different classes for better coverage.
It’s worth paying close attention to your response in the first few weeks. With pregabalin, meaningful relief often appears within the first couple of days. Duloxetine typically shows separation from placebo within the first week. If you’ve been on a medication at an adequate dose for four to six weeks with no improvement, that’s useful information, not a failure. It means that particular drug isn’t the right fit, and moving on to something else is reasonable. Most people with neuropathic pain find a medication or combination that brings their symptoms to a manageable level, even if complete elimination of pain isn’t realistic.